Migraine Pathophysiology: Role of Vasodilation
Vasodilation (widening of blood vessels) is a key component of migraine pathophysiology, particularly in the trigeminovascular system:
- Activation of trigeminal nerve endings around meningeal vessels → release of CGRP, substance P, neurokinin A.
- These neuropeptides cause vasodilation of meningeal arteries and plasma protein extravasation (neurogenic inflammation).
- Dilated vessels mechanically stimulate perivascular trigeminal afferents → sustained pain signaling to thalamus and cortex.
- Triptans/ergots constrict vessels via 5-HT1B/1D agonism; gepants block CGRP receptors without vasoconstriction.
Modern Understanding
Vasodilation is not the sole cause. Migraine originates in brainstem/hypothalamic nuclei (migraine generator) → cortical spreading depression (aura) → trigeminovascular activation. Vasodilation amplifies and sustains pain but is downstream of central initiation.
Clinical Relevance
- Explains throbbing quality (pulsatile distension).
- Guides drug development (triptans, gepants, ditans).
- Contraindicates vasoconstrictors in vascular disease.
Migraine - Related Articles
- Migraine Headaches: Symptoms, Signs & What to Do
- Migraine Treatment Alternatives to Paracetamol and Vasograin
- Understanding Chronic Migraines: Causes and Contributing Factors
- Migraine Triggers: Foods to Watch Out For
- Understanding the Link Between Birth Control and Migraine Relief
- Propranolol for Hormonal Migraines: Treatment & Relief
- Tension Headache vs. Migraine: Key Differences in Symptoms, Causes, and Relief
